# Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study

> **NCT02566720** · NA · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 10 (estimated)

## Conditions studied

- Acquired Brain Injury
- Coma
- Persistent Vegetative State
- Minimally Conscious State
- Traumatic Brain Injury

## Interventions

- **DRUG:** Amantadine
- **PROCEDURE:** MRI Tractography Study

## Key facts

- **NCT ID:** NCT02566720
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2015-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566720, "Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02566720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*